Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
Two KC EdTech startups earn spots in latest LEANLAB cohort; launch set for August
It’s a highly selective process to join the fifth LEANLAB K-12 fellowship, said Katie Boody, but two Kansas City startups made the cut. K12 Perform and Base Academy of Music will join four other cohort members — hailing from the Midwest to Washington D.C. — in the August-to-November EdTech accelerator program. LEANLAB is partnering…
HechoKC cast in hand-made image of Chicano artist’s culture, family, community
Witnessing — and participating in — Kansas City’s renaissance has been amazing, said Luis Garcia, the longtime artist behind HechoKC. The Crossroads used to be a ghost town, said Garcia, who has been part of the KC scene since his years at the Kansas City Art Institute. He developed SPYN Studio, a branding and design…
Quartet of startups hop into the Digital Sandbox KC
Four early-stage businesses recently entered the Digital Sandbox KC program. The new startups demonstrate the ingenuity Digital Sandbox aims to attract for its grant-funding efforts, said Jeff Shackelford, director of Digital Sandbox KC. “From helping students prepare for college to analyzing voting records to predict legislative outcomes, the startups in the Sandbox are a great…
Newest Techstars KC class tackling payday loans, food safety, bots for business
Techstars Kansas City has revealed its 2018 cohort of startups. The 10 companies will make a big impact not only on Kansas City but the global economy, said Lesa Mitchell, managing director of Techstars KC. “Although our companies come from many industries, they share in common that they are all solving problems to make the…